American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography

Debbie Saslow(American Cancer Society), C. Boetes(Radboud University Nijmegen), Wylie Burke(University of Washington Medical Center), S.E. Harms(University of Arkansas at Fayetteville), Martin O. Leach(Royal Marsden NHS Foundation Trust), Constance D. Lehman(Seattle Cancer Care Alliance), Elizabeth A. Morris(Memorial Sloan Kettering Cancer Center), Etta D. Pisano(University of North Carolina Health Care), Mitchell D. Schnall(University of Pennsylvania), S.F. Sener(Northwestern University), Robert A. Smith(American Cancer Society), Elizabeth Warner(Sunnybrook Health Science Centre), Yaffe Mj(Sunnybrook Health Science Centre), Kimberly Andrews(American Cancer Society), Christy Russell(University of Southern California), for the American Cancer Society Breast Cancer Advisory Group
CA A Cancer Journal for Clinicians
March 1, 2007
10.3322/canjclin.57.2.75
Cited by 2,647Open Access
Full Text

Abstract

New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20-25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.

Related Papers

No related papers found

Powered by citation graph analysis